These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 28776396)

  • 1. Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab')
    Jin C; Bai L; Lin L; Wang S; Yin X
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1076-1084. PubMed ID: 28776396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
    Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
    Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F(ab')(2) fragment and staphylococcal enterotoxin A.
    Yang LJ; Sui YF; Chen ZN
    World J Gastroenterol; 2001 Apr; 7(2):216-21. PubMed ID: 11819763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and in vitro killing effect of adriamycin-loaded immunonanosphere against hepatoma led by F (ab')2 Fragment of monoclonal antibodies].
    Li Y; Cai M; Wang Z; Liu X; Liang Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):8-11, 14. PubMed ID: 12599415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of targeted DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')2 for treatment of hepatocellular carcinoma.
    Jin C; Yang W; Bai L; Wang J; Dou K
    J Control Release; 2011 Nov; 152 Suppl 1():e14-5. PubMed ID: 22195807
    [No Abstract]   [Full Text] [Related]  

  • 7. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 9. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
    Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J
    Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
    Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
    Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular Carcinoma Targeting and Pharmacodynamics of Paclitaxel Nanoliposomes Modified by Glycyrrhetinic Acid and Ferric Tetroxide.
    Zhao L; Liang L; Guo M; Li M; Yu X; Wang Y; Wang Y
    Curr Top Med Chem; 2021 Oct; 21(14):1268-1284. PubMed ID: 34620053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cell penetrating peptide coated Mn:ZnS nanoparticles for paclitaxel delivery to cancer cells.
    Rejinold NS; Han Y; Yoo J; Seok HY; Park JH; Kim YC
    Sci Rep; 2018 Jan; 8(1):1899. PubMed ID: 29382898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.
    Lou C; Chen ZN; Bian HJ; Li J; Zhou SB
    World J Gastroenterol; 2002 Feb; 8(1):69-73. PubMed ID: 11833074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma.
    Wu M; Zhong C; Zhang Q; Wang L; Wang L; Liu Y; Zhang X; Zhao X
    J Nanobiotechnology; 2021 Feb; 19(1):39. PubMed ID: 33549107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
    Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
    J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma.
    Li T; Yu P; Chen Y; Sun B; Dong P; Zhu T; Meng X
    Eur J Med Chem; 2021 Oct; 222():113605. PubMed ID: 34126457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
    Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
    Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
    Shi L; Tang C; Yin C
    Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.